Commerzbank Analysts Split on Valuation as Orcel's Boardroom Play Nears Decision Point

Deutsche Bank downgraded Commerzbank to Hold with a EUR 42 target, as UniCredit seeks control and Berlin presses for binding commitments.

Deutsche Bank Research trimmed its recommendation on Commerzbank on Wednesday, cutting the Frankfurt lender to "Hold" from "Buy" while leaving the price target untouched at EUR 42. Analyst Benjamin Goy's move reflects a view that the stock's main catalysts have largely played out after a strong run in recent months.

The downgrade landed as the shares slipped 1.2% to EUR 41.08, though the stock is still up 14% since the start of the year.

Rate optimism and payouts already in the price

Deutsche Bank's reasoning rests on the argument that both interest-rate expectations and future capital distributions are now broadly reflected in the current valuation. Earnings forecasts for the bank have been revised higher of late, yet on a sector-relative basis Commerzbank's multiple has climbed above the average for European banks. That premium leaves less room for further gains, and with the stock trading just below the EUR 42 target, the analysts see additional momentum from the core interest business becoming harder to generate.

Not everyone on the sell side is turning cautious. A day earlier, Citigroup's Borja Ramírez Segura lifted his price target to EUR 42 from EUR 40 while keeping a "Neutral" rating. The revised target sits above the pre-market level of EUR 41.65, with the stock showing a 15% advance year to date.

UniCredit's grip tightens as approvals loom

Running alongside the valuation debate is the far larger question of who will control the bank. UniCredit has secured access to nearly half of Commerzbank's share capital, and chief executive Andrea Orcel is seeking operational control once regulatory clearances are in hand. The decisive rulings from supervisors — among them the European Central Bank, the EU Commission and Poland's financial regulator — are due between the end of October and December.

Should those approvals come through, UniCredit intends to convene an extraordinary general meeting in early 2027. The plan would replace all ten shareholder representatives on the 20-member supervisory board, a step that would likely also mark the end of CEO Bettina Orlopp's tenure. UniCredit declined to comment on the reports, according to dpa-AFX.

Orlopp, for her part, has argued for constructive dialogue with the Milan-based group. Speaking to Swiss business daily Finanz und Wirtschaft on Friday, she said the goal should be creating more value for shareholders and stakeholders. Over the medium term, she considers folding UniCredit's HypoVereinsbank subsidiary into Commerzbank conceivable — provided the Italian lender reaches the majority needed to make it happen.

Berlin sets its terms

Political resistance continues to harden. The German government holds a 13.3% stake in Commerzbank and wants two seats on the future supervisory board. Berlin is pressing UniCredit for binding commitments: that Commerzbank remain a listed stock corporation headquartered in Frankfurt, that it expand its mid-sized corporate lending business, and that key decisions be made in Germany. According to dpa-AFX, the government is also insisting on guarantees for employee rights and works council dialogue.

The Financial Times reported in parallel that Orcel is pushing to accelerate the takeover, with the boardroom overhaul and Orlopp's removal planned for the extraordinary meeting once the regulatory green light arrives.

Buyback rolls on ahead of November results

Away from the takeover drama, Commerzbank is pressing ahead with its announced capital measures. The bank repurchased 1,976,889 of its own shares between September 14 and September 18, bringing the total since September 4 to 4,217,261 shares.

Fresh insight into operating performance arrives in early November. Commerzbank has scheduled the release of its third-quarter 2026 figures for November 5, 2026.

For investors, the calculus has shifted. With fundamental valuation offering little upside in the eyes of sector watchers, the outcome of the takeover battle — and the wrangling over regulatory conditions — has moved firmly to center stage.